Cetuximab combined with chemotherapy is beneficial for patients with advanced non-small cell lung cancer after EGFR-tyrosine kinase inhibitors failure.
about
Cetuximab combined with chemotherapy is beneficial for patients with advanced non-small cell lung cancer after EGFR-tyrosine kinase inhibitors failure.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Cetuximab combined with chemot ...... ine kinase inhibitors failure.
@ast
Cetuximab combined with chemot ...... ine kinase inhibitors failure.
@en
type
label
Cetuximab combined with chemot ...... ine kinase inhibitors failure.
@ast
Cetuximab combined with chemot ...... ine kinase inhibitors failure.
@en
prefLabel
Cetuximab combined with chemot ...... ine kinase inhibitors failure.
@ast
Cetuximab combined with chemot ...... ine kinase inhibitors failure.
@en
P2093
P2860
P1476
Cetuximab combined with chemot ...... ine kinase inhibitors failure.
@en
P2093
P2860
P304
16140-16148
P577
2015-09-15T00:00:00Z